Chronic infusion of amyloid-β peptide and sustained attention altered α7 nicotinic receptor density in the rat brain

Current Alzheimer Research

Volumn 9, Issue 10, 2012, Pages 1210-1220

  Viel, Tania Araujo ^a   Caetano, Ariadiny Lima ^b   Albuquerque, Marilia Silva ^a   Araujo, Mariana Silva ^c   Buck, Hudson Sousa ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Alpha7 nicotinic receptor; Amygdala; Amyloid ; Attention; Hippocampus; Memory; Rehearsal

Indexed keywords

AMYLOID BETA PROTEIN; BUNGAROTOXIN RECEPTOR; METHYLLYCACONITINE;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATTENTION; AUTORADIOGRAPHY; AVOIDANCE BEHAVIOR; BRAIN CORTEX; BRAIN PROTECTION; CONTROLLED STUDY; HIPPOCAMPUS; INFUSION; MALE; MEMORY CONSOLIDATION; NERVE CELL PLASTICITY; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SUSTAINED ATTENTION;

AMYLOID BETA-PEPTIDES; ANALYSIS OF VARIANCE; ANIMALS; ATTENTION; AUTORADIOGRAPHY; AVOIDANCE LEARNING; BRAIN; BUNGAROTOXINS; HUMANS; IODINE ISOTOPES; MALE; PEPTIDE FRAGMENTS; PROTEIN BINDING; RATS; RATS, WISTAR; REACTION TIME; RECEPTORS, NICOTINIC; TIME FACTORS;

EID: 84874820680     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/156720512804142930     Document Type: Article

References (62)

1. Fujii S, Ji Z, Morita N, Sumikawa K. Acute and chronic nicotine exposure differentially facilitate the induction of LTP. Brain Res 846(1): 137-43 (1999).
2. Fujii S, Sumikawa K. Inactivation of α7 nicotinic ACh receptors and activation of non-α7 ACh receptors both contribute to long-term potentiation induction in the hippocampal CA1 region. Neurosci Lett 286: 134-8 (2000).
3. Matsuyama S, Matsumoto A. Epibatidine induces long-term potentiation (LTP) via activation of alpha4beta2 nicotinic acetylcholine receptors (nAChRs) in vivo in the intact mouse dentate gyrus: both alpha7 and alpha4beta2 nAChRs essential to nicotinic LTP. J Pharmacol Sci 93(2): 180-7 (2003).
4. Barros MD, Ramirez MR, Dos Reis EA, Izquierdo I. Participation of hippocampal nicotinic receptors in acquisition, consolidation and retrieval of memory for one trial inhibitory avoidance in rats. Neuroscience 126(3): 651-6 (2004).
5. Nott A, Levin ED. Dorsal hippocampal alpha7 and alpha4beta2 nicotinic receptors and memory. Brain Res 1081(1): 72-8 (2006).
6. Niewiadomska G, Baksalerska-Pazera M, Riedel G. The septohippocampal system, learning and recovery of function. Prog. Neuropsychopharmacol. Biol Psychiatry 33(5): 791-805 (2009).
7. Mielke JG, Mealing GAR. Cellular distribution of the nicotinic acetylcholine receptor a7 subunit in rat hippocampus. Neurosci Res 65: 296-306 (2009).
8. Boccia M M, Blake M G, Krawczyk M C, Baratti C M. Hippocampal alpha7 nicotinic receptors modulate memory reconsolidation of an inhibitory avoidance task in mice. Neuroscience 171: 531-43 (2010).
9. Hoyle E, Genn RF, Fernandes C, Stolerman IP. Impaired performance of alpha 7 nicotinic receptor knockout mice in the five-choice serial reaction time task. Psychopharmacol 189: 211-23 (2006).
10. Young JW, Crawford N, Kelly JS, Kerr LE, Marston HM, Spratt C, et al. Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice. Eur Neuropsychopharmacol 17: 145-55 (2007).
11. Rezvani AH, Kholdebarin E, Brucato FH, Callahan PM, Lowe DA, Levin ED. Effect of R3487/MEM3454, a novel nicotinic a7 receptor partial agonist and 5-HT3 antagonist on sustained attention in rats. Prog Neuropsychopharmacol Biol Psychiatry 33: 269-75 (2009).
12. Hake AM, Farlow MR. New concepts in the drug therapy of Alzheimer's disease. Expert Opin Pharmacother 2(12):1975-83 (2001).
13. Hogan DB, Patterson C. Treatment of Alzheimer's disease and other dementias - review and comparison of the cholinesterase inhibitors. Can J Neurol Sci 29: 306-14 (2002).
14. Hansen RA, Gartlehner G, Kaufer DJ, Lohr KN, Carey T. Drug class review on Alzheimer's drugs: final report [Internet]. Portland (OR): Oregon Health & Science University (2006).
15. Addy N, Nakajama A, Levin E. Nicotinic mechanisms of memory: effects of acute local DHbE and MLA infusions in the basolateral amygdala. Cogn Brain Res 16: 51-7 (2003).
16. Viveros MP, Marco EM, Llorente R, Lamota L. The role of the hippocampus in mediating emotional responses to nicotine and cannabinoids: a possible neural substrate for functional interactions. Behav Pharmacol 18(5-6): 375-89 (2007).
17. Torras M, Portell I, Morgado I. The amygdaloid body: functional implications. Rev Neurol 33(5): 471-6 (2001).
18. Sigurdsson T, Doyère V, Cain CK, LeDoux JE. Long-term potentiation in the amygdala: a cellular mechanism of fear learning and memory. Neuropharmacol 52(1): 215-27 (2007).
19. Rattiner LM, Davis M, Ressler KJ. Brain-derived neurotrophic factor in amygdala-dependent learning. Neuroscientist 11(4): 323-33 (2005).
20. Huang Y, Kandel ER, Levine A. Chronic nicotine exposure induces a long-lasting and pathway-specific facilitation of LTP in the amygdala. Learn Mem 15: 603-10 (2008).
21. Tribollet E, Bertrand D, Marguerat A, Raggenbass M. Comparative distribution of nicotinic receptor subtypes during development, adulthood and aging: an autoradiographic study in the rat brain. Neuroscience 12: 405-20 (2004).
22. Klein RC, Yakel JL. Functional somato-dendritic a7-containing nicotinic acetylcholine receptors in the rat basolateral amygdala complex. J Physiol 576(3): 865-72 (2006).
23. Shytle RD, Mori T, Townsend K, Vendrame M, Sun N, Zeng J et al. Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors. J Neurochem 89: 337-43 (2004).
24. Conejero-Goldberg C, Daviesa P, Ulloac L. Alpha7 nicotinic acetylcholine receptor: a link between inflammation and neurodegeneration. Neurosci Biobehav Res 32: 693-706 (2008).
25. Hunter RG, Bloss EB, McCarthy KJ, McEwen BS. Regulation of the nicotinic receptor alpha7 subunit by chronic stress and corticosteroids. Brain Res 1325: 141-6 (2010).
26. Viel TA, Lima-Caetano A, Nasello AG, Lancelotti CL, Nunes VA, Araujo MS et al. Increases of kinin B1 and B2 receptors binding sites after brain infusion of amyloid-beta 1-40 peptide in rats. Neurobiol Aging 12: 1805-14 (2008).
27. Frautschy SA, Horn DL, Sigel JJ, Harris-White ME, Mendoza JJ, Yang F et al. Protease inhibitor coinfusion with amyloid beta-protein results in enhanced deposition and toxicity in rat brain. J Neurosci 18(20): 8311-21 (1998).
28. Iores-Marçal LM, Viel TA, Buck HS, Nunes VA, Gozzo AJ, Cruz-Silva I, et al. Brain prolyl oligopeptidase inactivates bradykinin in a model of Alzheimer's disease. Peptides 27(12): 3363-69 (2006).
29. Amaral FA, Lemos MTR, Dong KE, Bittencourt MFQP, Caetano AL, Pesquero JB et al. Participation of kinin receptors on memory impairment after chronic infusion of human amyloid-β 1-40 peptide in mice. Neuropeptides 44(2): 93-7 (2010).
30. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. Academic Press, San Diego (2007).
31. Buck HS, Ongali B, Thibault G, Lindsey CJ, Couture R. Autoradiographic detection of kinin receptors in the human medulla of control, hypertensive, and diabetic donors. Can J Physiol Pharmacol 80(4): 249-257 (2002).
32. Popescu AT, Popa D, Paré D. Coherent gamma oscillations couple the amygdala and striatum during learning. Nat Neurosci 12(6): 801-7 (2009).
33. Davis M. The role of the amygdala in fear and anxiety. Annu Rev Neurosci 15: 353-75 (1992).
34. LeDoux JE. Emotion circuits in the brain. Annu Rev Neurosci 23: 155-84 (2000).
35. Amaral DG, Insausti R. Retrograde transport of D-[3H]-aspartate injected into the monkey amygdaloid complex. Exp Brain Res 88(2): 375-88 (1992).
36. Fendt M, Fanselow MS. The neuroanatomical and neurochemical basis of conditioned fear. Neurosci Biobehav Res 23: 743-60 (1999).
37. LeDoux JE, Iwata J, Cicchetti P, Reis DJ. Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear. J Neurosci 8(7): 2517-29 (1998).
38. Lemos MTR, Amaral FA, Dong KE, Bittencourt MF, Caetano AL, Pesquero JB et al. Role of kinin B1 and B2 receptors in memory consolidation during the aging process of mice. Neuropeptides 44(2): 163-8 (2010).
39. Izquierdo I, Cammarota M, Da Silva WC, Bevilaqua LRM, Rossato JI, Bonini JS et al. The evidence for hippocampal long-term potentiation as a basis of memory for simple tasks. Ann Br Acad Sc 80(1): 115-27 (2008).
40. Nitta A, Itoh A, Hasegawa T, Nabeshima T. Beta-amyloid proteininduced Alzheimer's disease animal model. Neurosci Lett 170(1): 63-6 (1994) [(erratum in: Neurosci Lett 172(1-2):180 (1994)].
41. Chen QS, Kagan BL, Hirakura Y, Xie CW. Impairment of hippocampal long-term potentiation by Alzheimer amyloid beta-peptides. J Neurosci Res 60: 65-72 (2000).
42. Freir DB, Herron CE. Nicotine enhances the depressive actions of Ab1-40 on long-term potentiation in the rat hippocampal CA1 region in vivo. J Neurophysiol 89: 2917-22 (2003).
43. Court J, Martin-Ruiz C, Piggott M, Spurden D, Griffiths M, Perry E. Nicotinic receptor abnormalities in Alzheimer's disease. Biol Psychiatry 49: 175-84 (2001).
44. Wang H, Liao HY, Ochani M, Justiniani M, Lin X, Yang L et al. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis [see comment]. Nat Med 10: 1216-21 (2004).
45. De Rosa MJ, Esandi Mdel C, Garelli A, Rayes D, Bouzat C. Relationship between alpha 7 nAChR and apoptosis in human lymphocytes. J Neuroimmunol 160: 154-61 (2005).
46. Tyagi E, Agrawal R, Nath C, Shukla R. Cholinergic protection via a7 nicotinic acetylcholine receptors and PI3K-Akt pathway in LPSinduced neuroinflammation. Neurochem Int 56: 135-42 (2010).
47. Rosas-Ballina M, Tracey KJ. Cholinergic control of inflammation. J Intern Med 265(6): 663-79 (2009).
48. Schauz C, Koch M. Blockade of NMDA receptors in the amygdala prevents latent inhibition of fear-conditioning. Learn Mem 7(6): 393-99 (2000).
49. Lalumiere RT, Nguyen LT, McGaugh JL. Post-training intrabasolateral amygdala infusions of dopamine modulate consolidation of inhibitory avoidance memory: involvement of noradrenergic and cholinergic systems. Eur J Neurosci 20(10): 2804-10 (2004).
50. Roozendaal B, Hahn EL, Nathan SV, de Quervain DJ, McGaugh JL. Glucocorticoid effects on memory retrieval require concurrent noradrenergic activity in the hippocampus and basolateral amygdala. J Neurosci 24(37): 8161-69 (2004).
51. Zhou R, Wang S, Zhu X. Prenatal ethanol exposure attenuates GABAergic inhibition in basolateral amygdala leading to neuronal hyperexcitability and anxiety-like behavior of adult rat offspring. Neuroscience 170(3):749-57 (2010).
52. Maren S. Neurobiology of Pavlovian fear conditioning. Annu Rev Neurosci 24: 897-931 (2001).
53. Maren S. Synaptic mechanisms of associative memory in the amygdala. Neuron 47(6): 783-6 (2005).
54. Zhang Z-W, Deschênes, M. Intracortical axonal projections of lamina VI cells of the primary somatosensory cortex in the rat: a singlecell labeling study. J Neurosci 17(16): 6365-79 (1997).
55. DeKosky ST, Bass NH. Aging, senile dementia, and the intralaminar microchemistry of cerebral cortex. Neurology 32(11): 1227-33 (1982).
56. Csillik B, Nemcsók J, Boncz I, Knyihár-Csillik E. Nitric oxide synthase and the acetylcholine receptor in the prefrontal cortex: metasynaptic organization of the brain. Neurobiol (Bp) 6(4): 383-404 (1998).
57. Kawai H, Zago W, Berg DK. Nicotinic alpha 7 receptor clusters on hippocampal GABAergic neurons: regulation by synaptic activity and neurotrophins. J Neurosci 22(18):7903-12 (2002).
58. Zhou X, Nai Q, Chen M, Dittus JD, Howard MJ, Margiotta JF. Brain-derived neurotrophic factor and TrkB signaling in parasympathetic neurons: relevance to regulating alpha7-containing nicotinic receptors and synaptic function. J Neurosci 24(18): 4340-50 (2004).
59. Massey KA, Zago WM, Berg DK. BDNF up-regulates alpha7 nicotinic acetylcholine receptor levels on subpopulations of hippocampal interneurons. Mol Cell Neurosci 33(4): 381-8 (2006).
60. Jones IW, Wonnacott S. Precise localization of {alpha}7 nicotinic acetylcholine receptors on glutamatergic axon terminals in the rat ventral tegmental area. J Neurosci 24(50): 11244-52 (2004).
61. Johnstone TB, Gu Z, Yoshimura RF, Villegier A-S, Hogenkamp DJ, Whittemore ER, et al. Allosteric Modulation of Related Ligand-Gated Ion Channels Synergistically Induces Long-Term Potentiation in the Hippocampus and Enhances Cognition J. Pharmacol. Experim. Ther. 336(3), 908-915 (2011).
62. Kawamata J, Shimohama S. Stimulating nicotinic receptors trigger multiple pathways attenuating citotoxicity in models of Alzheimer's and Parkinson's diseases. J. Alzheimer. Dis. 24, 95-109 (2011).